Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PH domain containing endocytic trafficking adaptor 1 (PHETA1) is a protein coding gene whose product localizes primarily to endosomes and is essential for the process of endocytic trafficking, where it regulates the recycling of receptors from endosomes to both the plasma membrane and the trans-Golgi network. PHETA1 interacts directly with the inositol polyphosphate 5-phosphatase OCRL-1 and is involved in endosome organization, receptor recycling, and retrograde endosomal transport. The protein contains a PH (pleckstrin homology) domain, mediating specific protein and lipid interactions related to its trafficking adapter function. Disease associations include Lowe oculocerebrorenal syndrome and Leopard syndrome 1, but PHETA1 itself is not currently considered a direct therapeutic target, nor are there drugs or established biomarkers directly linked to it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PH domain containing endocytic trafficking adaptor 1 (PHETA1).